Medtronic 2012 Annual Report Download - page 21

Download and view the complete annual report

Please find page 21 of the 2012 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 152

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152

Peripheral Vascular Intervention (PVI). PVI encompasses a variety of procedures to treat patients
with PVD, a narrowing or blockage of vessels outside the heart which impedes blood supply to the brain,
kidneys, legs, and other vital organs. Similar to CAD, PVD is commonly treated with balloon angioplasty
which can be followed up with a peripheral stent. Our PVI products include the Complete SE stent, Assurant
Cobalt Iliac Stent, Pioneer Plus lumen re-entry device, percutaneous angioplasty balloons, drug-eluting
balloons for coronary and lower-extremity vessels, as well as embolic protection devices and stents for the
treatment of carotid artery disease.
The Structural Heart business offers a comprehensive line of products and therapies to treat a variety
of heart valve disorders. Our products include products for the repair and replacement of heart valves,
perfusion systems, positioning and stabilization systems for beating heart revascularization surgery, and
surgical ablation products. The following are our principal products offered by our Structural Heart business:
Heart Valves. We offer a complete line of surgical valve replacement and repair products for damaged
or diseased heart valves. Our replacement products include both tissue and mechanical valves. Our
replacement tissue valve product offerings include the Mosaic bioprosthetic stented, Freestyle stentless,
Hancock II stented valves, and 3f Biological tissue valve. Our mechanical valves include the Open Pivot
valve. Our valve repair products include the Duran Flexible and CG Future Band, the CG Composite
Annuloplasty Systems, the Profile 3D Annuloplasty Ring, the Simulus Ring portfolio, and the Tri-Ad
Annuloplasty Ring.
Transcatheter Heart Valves. Transcatheter valve (TCV) technology represents a less invasive means
to treat heart valve disease and is designed to allow physicians to deliver replacement valves via a catheter
through the body’s cardiovascular system, eliminating the need to open the chest. Our TCVs include the
Melody pulmonary valve and the CoreValve aortic valve. The Melody has received CE Mark approval as
well as U.S. FDA approval under a Humanitarian Device Exemption (HDE). CoreValve has received CE
Mark approval and is currently being clinically studied in the U.S. for approval.
Arrested Heart Surgery. In conventional coronary artery bypass graft procedures and heart valve
surgery, the patient’s heart is temporarily stopped, or arrested. The patient is placed on a circulatory support
system that temporarily functions as the patient’s heart and lungs and provides blood flow to the body. We
offer a complete line of blood-handling products that form this circulatory support system and maintain and
monitor blood circulation and coagulation status, oxygen supply, and body temperature during arrested
heart surgery.
Beating Heart Surgery. To assist physicians performing beating heart surgery, we offer positioning and
stabilization technologies. These technologies include our Starfish 2 and Urchin heart positioners, which
are designed to work in concert with our family of Octopus tissue stabilizers.
Surgical Ablation. Our Cardioblate surgical ablation system, which includes the Cardioblate LP
surgical ablation system, the Cardioblate navigator tissue dissector, and the Cardioblate Cryoflex system,
allows cardiac surgeons to create ablation lines during cardiac surgery.
The charts below set forth net sales of our CardioVascular products as a percentage of our total net sales
for each of the last three fiscal years:
4
CardioVascular
$3,475
All Other
$12,709
Fiscal Year 2012
(dollars in millions)
CardioVascular
$3,109
All Other
$12,399
Fiscal Year 2011
(dollars in millions)
CardioVascular
$2,864
All Other
$12,528
Fiscal Year 2010
(dollars in millions)
20%
80%
21%
79%
19%
81%